Clinical Trials

Pembrolizumab +/- SD-101 in Hormone-Naïve Oligometastatic Prostate Cancer With RT and iADT

Number: NCT03007732
PHEN Patient Summary Information
Trial Phase: Phase 2
Sponsor(s): Lawrence Fong|Prostate Cancer Foundation|Merck Sharp & Dohme Corp.|Dynavax Technologies Corporation|University of California, San Francisco
Sponsor Trial Information
Trial Location(s) and Contact(s)

Total: 1 Clinical Trials

PHEN,Inc. © 2021 All rights reserved